Top

Published in:

01-06-2018

Cardiovascular disease incidence in adolescent and young adult cancer survivors: a retrospective cohort study

Authors: Theresa H. M. Keegan, Lawrence H. Kushi, Qian Li, Ann Brunson, X. Chawla, Helen K. Chew, Marcio Malogolowkin, Ted Wun

Published in: Journal of Cancer Survivorship | Issue 3/2018

Abstract

Purpose

Few population-based studies have focused on cardiovascular disease (CVD) risk in adolescent and young adult (AYA; 15–39 years) cancer survivors and none have considered whether CVD risk differs by sociodemographic factors.

Methods

Analyses focused on 79,176 AYA patients diagnosed with 14 first primary cancers in 1996–2012 and surviving > 2 years after diagnosis with follow-up through 2014. Data were obtained from the California Cancer Registry and State hospital discharge data. CVD included coronary artery disease, heart failure, and stroke. The cumulative incidence of developing CVD accounted for the competing risk of death. Multivariable Cox proportional hazards regression evaluated factors associated with CVD and the impact of CVD on mortality.

Results

Overall, 2249 (2.8%) patients developed CVD. Survivors of central nervous system cancer (7.3%), acute lymphoid leukemia (6.9%), acute myeloid leukemia (6.8%), and non-Hodgkin lymphoma (4.1%) had the highest 10-year CVD incidence. In multivariable models, African-Americans (hazard ratio (HR) = 1.55, 95% confidence interval (CI) = 1.33–1.81; versus non-Hispanic Whites), those with public/no health insurance (HR = 1.78, 95% CI = 1.61–1.96; versus private) and those who resided in lower socioeconomic status neighborhoods had a higher CVD risk. These sociodemographic differences in CVD incidence were apparent across most cancer sites. The risk of death was increased by eightfold or higher among AYAs who developed CVD.

Conclusion

While cancer therapies are known to increase the risk of CVD, this study additionally shows that CVD risk varies by sociodemographic factors.

Implications for cancer survivors

The identification and mitigation of CVD risk factors in these subgroups may improve long-term patient outcomes.

Available only for authorised users

Nass SJ, Beaupin LK, Demark-Wahnefried W, Fasciano K, Ganz PA, Hayes-Lattin B, et al. Identifying and addressing the needs of adolescents and young adults with cancer: summary of an institute of medicine workshop. Oncologist. 2015;20(2):186–95. https://doi.org/10.1634/theoncologist.2014-0265.CrossRefPubMedPubMedCentral

Scholz-Kreisel P, Spix C, Blettner M, Eckerle S, Faber J, Wild P, et al. Prevalence of cardiovascular late sequelae in long-term survivors of childhood cancer: a systematic review and meta-analysis. Pediatr Blood Cancer. 2017;64(7) https://doi.org/10.1002/pbc.26428.

Chao C, Xu L, Bhatia S, Cooper R, Brar S, Wong FL, et al. Cardiovascular disease risk profiles in survivors of adolescent and young adult (AYA) cancer: the Kaiser Permanente AYA cancer survivors study. J Clin Oncol. 2016;34(14):1626–33. https://doi.org/10.1200/JCO.2015.65.5845.CrossRefPubMed

Rugbjerg K, Mellemkjaer L, Boice JD, Kober L, Ewertz M, Olsen JH. Cardiovascular disease in survivors of adolescent and young adult cancer: a Danish cohort study, 1943–2009. J Natl Cancer Inst. 2014;106(6):dju110. https://doi.org/10.1093/jnci/dju110.CrossRefPubMed

Van Laar M, Feltbower RG, Gale CP, Bowen DT, Oliver SE, Glaser A. Cardiovascular sequelae in long-term survivors of young peoples’ cancer: a linked cohort study. Br J Cancer. 2014;110(5):1338–41. https://doi.org/10.1038/bjc.2014.37.CrossRefPubMedPubMedCentral

Kero AE, Jarvela LS, Arola M, Malila N, Madanat-Harjuoja LM, Matomaki J, et al. Cardiovascular morbidity in long-term survivors of early-onset cancer: a population-based study. Int J Cancer. 2014;134(3):664–73. https://doi.org/10.1002/ijc.28385.CrossRefPubMed

Henson KE, Reulen RC, Winter DL, Bright CJ, Fidler MM, Frobisher C, et al. Cardiac mortality among 200,000 five-year survivors of cancer diagnosed at 15 to 39 years of age: the teenage and young adult cancer survivor study. Circulation. 2016;134(20):1519–31. https://doi.org/10.1161/CIRCULATIONAHA.116.022514.CrossRefPubMedPubMedCentral

Bright CJ, Hawkins MM, Guha J, Henson KE, Winter DL, Kelly JS, et al. Risk of cerebrovascular events in 178 962 five-year survivors of cancer diagnosed at 15 to 39 years of age: the TYACSS (Teenage and Young Adult Cancer Survivor Study). Circulation. 2017;135(13):1194–210. https://doi.org/10.1161/CIRCULATIONAHA.116.025778.CrossRefPubMed

Derouen MC, Gomez SL, Press DJ, Tao L, Kurian AW, Keegan TH. A population-based observational study of first-course treatment and survival for adolescent and young adult females with breast cancer. J Adolesc Young Adult Oncol. 2013;2(3):95–103. https://doi.org/10.1089/jayao.2013.0004.CrossRefPubMedPubMedCentral

10.

Keegan TH, Grogan RH, Parsons HM, Tao L, White MG, Onel K, et al. Sociodemographic disparities in differentiated thyroid cancer survival among adolescents and young adults in california. Thyroid. 2015;25(6):635–48. https://doi.org/10.1089/thy.2015.0021.CrossRefPubMedPubMedCentral

11.

Keegan TH, Press DJ, Tao L, DeRouen MC, Kurian AW, Clarke CA, et al. Impact of breast cancer subtypes on 3-year survival among adolescent and young adult women. Breast Cancer Res. 2013;15(5):R95. https://doi.org/10.1186/bcr3556.CrossRefPubMedPubMedCentral

12.

Aizer AA, Falit B, Mendu ML, Chen MH, Choueiri TK, Hoffman KE, et al. Cancer-specific outcomes among young adults without health insurance. J Clin Oncol. 2014;32(19):2025–30. https://doi.org/10.1200/JCO.2013.54.2555.CrossRefPubMedPubMedCentral

13.

Kent EE, Morris RA, Largent JA, Ziogas A, Sender LS, Anton-Culver H. Socioeconomic impacts on survival differ by race/ethnicity among adolescents and young adults with non-Hodgkin’s lymphoma. J Cancer Epidemiol. 2010;2010:824691. https://doi.org/10.1155/2010/824691.CrossRefPubMedPubMedCentral

14.

Rosenberg AR, Kroon L, Chen L, Li CI, Jones B. Insurance status and risk of cancer mortality among adolescents and young adults. Cancer. 2015;121(8):1279–86. https://doi.org/10.1002/cncr.29187.CrossRefPubMed

15.

Keegan TH, DeRouen MC, Parsons HM, Clarke CA, Goldberg D, Flowers CR, et al. Impact of treatment and insurance on socioeconomic disparities in survival after adolescent and young adult Hodgkin lymphoma: a population-based study. Cancer Epidemiol Biomark Prev. 2016;25(2):264–73. https://doi.org/10.1158/1055-9965.EPI-15-0756.CrossRef

16.

Keegan TH, Tao L, DeRouen MC, Wu XC, Prasad P, Lynch CF, et al. Medical care in adolescents and young adult cancer survivors: what are the biggest access-related barriers. J Cancer Surviv. 2014;8(2):282–92. https://doi.org/10.1007/s11764-013-0332-4.CrossRefPubMedPubMedCentral

17.

Parsons HM, Schmidt S, Harlan LC, Kent EE, Lynch CF, Smith AW, et al. Young and uninsured: insurance patterns of recently diagnosed adolescent and young adult cancer survivors in the AYA HOPE study. Cancer. 2014;120(15):2352–60. https://doi.org/10.1002/cncr.28685.CrossRefPubMedPubMedCentral

18.

Chao C, Chiu V, Mueller LA, Cooper R. Exploring the feasibility of establishing a retrospective cohort of survivors of adolescent and young adult cancer to study long-term health outcomes in an integrated managed care environment. J Adolesc Young Adult Oncol. 2013;2(2):59–65. https://doi.org/10.1089/jayao.2012.0024.CrossRefPubMedPubMedCentral

19.

Barr RD, Holowaty EJ, Birch JM. Classification schemes for tumors diagnosed in adolescents and young adults. Cancer. 2006;106(7):1425–30. https://doi.org/10.1002/cncr.21773.CrossRefPubMed

20.

Wu HC, Wang Q, Chung WK, Andrulis IL, Daly MB, John EM, et al. Correlation of DNA methylation levels in blood and saliva DNA in young girls of the LEGACY girls study. Epigenetics. 2014;9(7):929–33. https://doi.org/10.4161/epi.28902.CrossRefPubMedPubMedCentral

21.

Smith EC, Ziogas A, Anton-Culver H. Association between insurance and socioeconomic status and risk of advanced stage Hodgkin lymphoma in adolescents and young adults. Cancer. 2012;118(24):6179–87. https://doi.org/10.1002/cncr.27684.CrossRefPubMed

22.

Yost K, Perkins C, Cohen R, Morris C, Wright W. Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control. 2001;12(8):703–11. https://doi.org/10.1023/A:1011240019516.CrossRefPubMed

23.

Lin G, So Y, Johnston G. Analyzing survival data with competing risks using SAS® software. Cary: SAS Institute Inc; 2012.

24.

Gray R. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16(3):1141–54. https://doi.org/10.1214/aos/1176350951.CrossRef

25.

Jain D, Russell RR, Schwartz RG, Panjrath GS, Aronow W. Cardiac complications of cancer therapy: pathophysiology, identification, prevention, treatment, and future directions. Curr Cardiol Rep. 2017;19(5):36. https://doi.org/10.1007/s11886-017-0846-x.CrossRefPubMed

26.

Russell RR, Alexander J, Jain D, Poornima IG, Srivastava AV, Storozynsky E, et al. The role and clinical effectiveness of multimodality imaging in the management of cardiac complications of cancer and cancer therapy. J Nucl Cardiol. 2016;23(4):856–84. https://doi.org/10.1007/s12350-016-0538-8.CrossRefPubMed

27.

Armenian SH. Anthracycline-induced cardiotoxicity in young cancer patients: the role of carnitine. Ann Nutr Metab. 2016;68(Suppl 3):10–4. https://doi.org/10.1159/000448322.CrossRefPubMed

28.

Berkman AM, Lakoski SG. Treatment, behavioral, and psychosocial components of cardiovascular disease risk among survivors of childhood and young adult cancer. J Am Heart Assoc. 2015;4(4):e001891. https://doi.org/10.1161/JAHA.115.001891.CrossRefPubMedPubMedCentral

29.

Rotz SJ, Ryan TD, Hlavaty J, George SA, El-Bietar J, Dandoy CE. Cardiotoxicity and cardiomyopathy in children and young adult survivors of hematopoietic stem cell transplant. Pediatr Blood Cancer. 2017;64(11) https://doi.org/10.1002/pbc.26600.

30.

Tai E, Buchanan N, Townsend J, Fairley T, Moore A, Richardson LC. Health status of adolescent and young adult cancer survivors. Cancer. 2012;118(19):4884–91. https://doi.org/10.1002/cncr.27445.CrossRefPubMedPubMedCentral

31.

Ng AK. Current survivorship recommendations for patients with Hodgkin lymphoma: focus on late effects. Blood. 2014;124(23):3373–9. https://doi.org/10.1182/blood-2014-05-579193.CrossRefPubMed

32.

Ng AK. Review of the cardiac long-term effects of therapy for Hodgkin lymphoma. Br J Haematol. 2011;154(1):23–31. https://doi.org/10.1111/j.1365-2141.2011.08713.x.CrossRefPubMed

33.

Kirchhoff AC, Lyles CR, Fluchel M, Wright J, Leisenring W. Limitations in health care access and utilization among long-term survivors of adolescent and young adult cancer. Cancer. 2012;118(23):5964–72. https://doi.org/10.1002/cncr.27537.CrossRefPubMed

34.

Kaul S, Fluchel M, Spraker-Perlman H, Parmeter CF, Kirchhoff AC. Health care experiences of long-term survivors of adolescent and young adult cancer. Support Care Cancer. 2016;24(9):3967–77. https://doi.org/10.1007/s00520-016-3235-x.CrossRefPubMed

35.

Guy GP Jr, Yabroff KR, Ekwueme DU, Virgo KS, Han X, Banegas MP, et al. Healthcare expenditure burden among non-elderly cancer survivors, 2008-2012. Am J Prev Med. 2015;49(6 Suppl 5):S489–97. https://doi.org/10.1016/j.amepre.2015.09.002.CrossRefPubMedPubMedCentral

36.

Bleyer A, Ulrich C, Young MS. Adults, cancer, health insurance, socioeconomic status, and the patient protection and affordable care act. Cancer. 2012;118(24):6018–21. https://doi.org/10.1002/cncr.27685.CrossRefPubMed

37.

Adams SH, Newacheck PW, Park MJ, Brindis CD, Irwin CE Jr. Health insurance across vulnerable ages: patterns and disparities from adolescence to the early 30s. Pediatrics. 2007;119(5):e1033–9. https://doi.org/10.1542/peds.2006-1730.CrossRefPubMed

38.

Berkman AM, Brewster AM, Jones LW, Yu J, Lee JJ, Peng SA, et al. Racial differences in 20-year cardiovascular mortality risk among childhood and young adult cancer survivors. J Adolesc Young Adult Oncol. 2017; https://doi.org/10.1089/jayao.2017.0024.

39.

Centers for Disease Control and Prevention. Coronary heart disease and stroke deaths—United States, 2009. MMWR. 2013;62(Suppl 3):157–60.

40.

Schootman M, Deshpande AD, Pruitt SL, Aft R, Jeffe DB. National estimates of racial disparities in health status and behavioral risk factors among long-term cancer survivors and non-cancer controls. Cancer Causes Control. 2010;21(9):1387–95. https://doi.org/10.1007/s10552-010-9566-x.CrossRefPubMedPubMedCentral

41.

White A, Pollack LA, Smith JL, Thompson T, Underwood JM, Fairley T. Racial and ethnic differences in health status and health behavior among breast cancer survivors—behavioral risk factor surveillance system, 2009. J Cancer Surviv. 2013;7(1):93–103. https://doi.org/10.1007/s11764-012-0248-4.CrossRefPubMed

42.

Ness KK, Leisenring WM, Huang S, Hudson MM, Gurney JG, Whelan K, et al. Predictors of inactive lifestyle among adult survivors of childhood cancer: a report from the childhood cancer survivor study. Cancer. 2009;115(9):1984–94. https://doi.org/10.1002/cncr.24209.CrossRefPubMedPubMedCentral

43.

Liu Q, Leisenring WM, Ness KK, Robison LL, Armstrong GT, Yasui Y, et al. Racial/ethnic differences in adverse outcomes among childhood cancer survivors: the childhood cancer survivor study. J Clin Oncol. 2016;34(14):1634–43. https://doi.org/10.1200/JCO.2015.66.3567.CrossRefPubMedPubMedCentral

44.

Landier W, Chen Y, Namdar G, Francisco L, Wilson K, Herrera C, et al. Impact of tailored education on awareness of personal risk for therapy-related complications among childhood cancer survivors. J Clin Oncol. 2015;33(33):3887–93. https://doi.org/10.1200/JCO.2015.62.7562.CrossRefPubMedPubMedCentral

45.

Kaul S, Veeranki SP, Rodriguez AM, Kuo YF. Cigarette smoking, comorbidity, and general health among survivors of adolescent and young adult cancer. Cancer. 2016;122(18):2895–905. https://doi.org/10.1002/cncr.30086.CrossRefPubMed

46.

Kanjilal S, Gregg EW, Cheng YJ, Zhang P, Nelson DE, Mensah G, et al. Socioeconomic status and trends in disparities in 4 major risk factors for cardiovascular disease among US adults, 1971-2002. Arch Intern Med. 2006;166(21):2348–55. https://doi.org/10.1001/archinte.166.21.2348.CrossRefPubMed

47.

Odutayo A, Gill P, Shepherd S, Akingbade A, Hopewell S, Tennankore K, et al. Income disparities in absolute cardiovascular risk and cardiovascular risk factors in the United States, 1999-2014. JAMA Cardiol. 2017;2(7):782–90. https://doi.org/10.1001/jamacardio.2017.1658.CrossRefPubMedPubMedCentral

Title: Cardiovascular disease incidence in adolescent and young adult cancer survivors: a retrospective cohort study
Authors: Theresa H. M. Keegan
Lawrence H. Kushi
Qian Li
Ann Brunson
X. Chawla
Helen K. Chew
Marcio Malogolowkin
Ted Wun
Publication date: 01-06-2018
Publisher: Springer US
Published in: Journal of Cancer Survivorship / Issue 3/2018
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI: https://doi.org/10.1007/s11764-018-0678-8

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Implications for cancer survivors

Please log in to get access to this content

Other articles of this Issue 3/2018

The continuum of breast cancer care and outcomes in the U.S. Military Health System: an analysis by benefit type and care source

Interventions to improve endocrine therapy adherence in breast cancer survivors: what is the evidence?

Predictors of vasomotor symptoms among breast cancer survivors

Survivorship care plan outcomes for primary care physicians, cancer survivors, and systems: a scoping review

Development of the Cancer Survivor Profile-Breast Cancer (CSPro-BC) app: patient and nurse perspectives on a new navigation tool

Consumer credit as a novel marker for economic burden and health after cancer in a diverse population of breast cancer survivors in the USA

Keynote webinar | Spotlight on antibody–drug conjugates in cancer